Adial Pharmaceuticals, Inc. (ADIL)
6.65
-0.47
(-6.60%)
USD |
NASDAQ |
Sep 08, 16:00
6.65
0.00 (0.00%)
Pre-Market: 08:37
Adial Pharmaceuticals Debt to Equity Ratio : -1.624 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.624 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.1346 |
| December 31, 2022 | 0.0173 |
| September 30, 2022 | 0.0407 |
| June 30, 2022 | 0.0292 |
| March 31, 2022 | 0.0229 |
| December 31, 2021 | 0.0733 |
| September 30, 2021 | 0.0372 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0566 |
| March 31, 2021 | 0.0557 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0281 |
| June 30, 2018 | -0.7716 |
| March 31, 2018 | -0.7415 |
| December 31, 2017 | -0.691 |
| September 30, 2017 | -0.7757 |
| June 30, 2017 | -1.067 |
| March 31, 2017 | -0.9614 |
| December 31, 2016 | -2.264 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 29.09M |
| Total Liabilities (Quarterly) | 67.47M |
| Shareholders Equity (Quarterly) | -38.38M |
| Current Ratio | 5.633 |
| Net Debt Paydown Yield | -185.5% |